future of glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog GLP-1 Drugs Market Size to
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials
It has been clinically studied to help support GLP-1 levels and may support positive gut flora
Learn how this impacts injury risk, recovery, and long-term function.
They are primarily used in the management of type 2 diabetes (T2D).
- **Curb appetite:** Helping individuals feel full, potentially leading to reduced food intake
